Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1975 Nov;72(11):4425–4429. doi: 10.1073/pnas.72.11.4425

Chemical induction of sperm abnormalities in mice.

A J Wyrobek, W R Bruce
PMCID: PMC388734  PMID: 1060122

Abstract

The sperm of (C57BL X C3H)F1 mice were examined 1, 4, and 10 weeks after a subacute treatment with one of 25 chemicals at two or more dose levels. The fraction of sperm that were abnormal in shape was elevated above control values of 1.2-3.4% for methyl methanesulfonate, ethyl methanesulfonate, griseofulvin, benzo[a]pyrene, METEPA [tris(2-methyl-l-aziridinyl)phosphine oxide], THIO-TEPA [tris(l-aziridinyl)phosphine sulfide], mitomycin C, myleran, vinblastine sulphate, hydroxyurea, 3-methylcholanthrene, colchicine, actinomycin D, imuran, cyclophosphamide, 5-iododeoxyuridine, dichlorvos, aminopterin, and trimethylphosphate. Dimethylnitrosamine, urethane, DDT [1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane], 1,1-dimethylhydrazine, caffeine, and calcium cyclamate did not induce elevated levels of sperm abnormalities. The results suggest that sperm abnormalities might provide a rapid inexpensive mammalian screen for agents that lead to errors in the differentiation of spermatogenic stem cells in vivo and thus indicate agents which might prove to be mutagenic, teratogenic, or carcinogenic.

Full text

PDF
4425

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS C. E., HAY M. F., LUTWAK-MANN C. The action of various agents upon the rabbit embryo. J Embryol Exp Morphol. 1961 Sep;9:468–491. [PubMed] [Google Scholar]
  2. ARMSTRONG J. G., DYKE R. W., FOUTS P. J. VINBLASTINE SULFATE TREATMENT OF HODGKIN'S DISEASE DURING A PREGNANCY. Science. 1964 Feb 14;143(3607):703–703. doi: 10.1126/science.143.3607.703. [DOI] [PubMed] [Google Scholar]
  3. Adler I. D. Does caffeine induce dominant lethal mutations in mice? Humangenetik. 1969;7(2):137–148. doi: 10.1007/BF00287078. [DOI] [PubMed] [Google Scholar]
  4. Adler I. D., Röhrborn G. Cytogenetic investigation of meiotic chromosomes of male mice after chronic caffeine treatment. Humangenetik. 1969 Oct;8(2):81–85. doi: 10.1007/BF00295830. [DOI] [PubMed] [Google Scholar]
  5. Bempong M. A., Trower E. C. Sensitivity of rat testis to inhibitors of nucleic acid synthesis. II. Mutagenic action of mitomycin C. J Hered. 1973 Nov-Dec;64(6):324–328. doi: 10.1093/oxfordjournals.jhered.a108432. [DOI] [PubMed] [Google Scholar]
  6. Bruce W. R., Furrer R., Wyrobek A. J. Abnormalities in the shape of murine sperm after acute testicular x-irradiation. Mutat Res. 1974 Jun;23(3):381–386. doi: 10.1016/0027-5107(74)90112-2. [DOI] [PubMed] [Google Scholar]
  7. Bryan G. T., Ertürk E. Production of mouse urinary bladder carcinomas by sodium cyclamate. Science. 1970 Feb 13;167(3920):996–998. doi: 10.1126/science.167.3920.996. [DOI] [PubMed] [Google Scholar]
  8. CATTANACH B. M. Genetical effects of caffeine in mice. Z Vererbungsl. 1962;93:215–219. doi: 10.1007/BF00889163. [DOI] [PubMed] [Google Scholar]
  9. Cattanach B. M., Williams C. E. A search for chromosome aberrations induced in mouse spermatogonia by chemical mutagens. Mutat Res. 1971 Dec;13(4):371–375. doi: 10.1016/0027-5107(71)90048-0. [DOI] [PubMed] [Google Scholar]
  10. Collin J. P. Effet cytogénétique du cyclamate de soude, de la cyclohéxanone et du cyclohéxanol. Diabete. 1971 Oct-Dec;19(4):215–221. [PubMed] [Google Scholar]
  11. Dean B. J., Doak S. M., Funnell J. Genetic studies with dichlorvos in the host-mediated assay and in liquid medium using Saccharomyces cerevisiae. Arch Toxikol. 1972;30(1):61–66. doi: 10.1007/BF00605274. [DOI] [PubMed] [Google Scholar]
  12. Dean B. J., Thorpe E. Cytogenetic studies with dichlorvos in mice and Chinese hamsters. Arch Toxikol. 1972;30(1):39–49. doi: 10.1007/BF00605272. [DOI] [PubMed] [Google Scholar]
  13. Dean B. J., Thorpe E. Studies with dichlorvos vapour in dominant lethal mutation tests on mice. Arch Toxikol. 1972;30(1):51–59. doi: 10.1007/BF00605273. [DOI] [PubMed] [Google Scholar]
  14. Deichmann W. B. Research, DDT and cancer. IMS Ind Med Surg. 1972 Aug;41(8):15–18. [PubMed] [Google Scholar]
  15. Durston W. E., Ames B. N. A simple method for the detection of mutagens in urine: studies with the carcinogen 2-acetylaminofluorene. Proc Natl Acad Sci U S A. 1974 Mar;71(3):737–741. doi: 10.1073/pnas.71.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eberle P., Hunstein W., Perings E. Chromosomes in patients treated with Imuran. Humangenetik. 1968;6(1):69–73. doi: 10.1007/BF00287156. [DOI] [PubMed] [Google Scholar]
  17. Elis J., DiPaolo J. A. The alteration of actinomycin D teratogenicity by hormones and nucleic acids. Teratology. 1970 Feb;3(1):33–38. doi: 10.1002/tera.1420030108. [DOI] [PubMed] [Google Scholar]
  18. Epstein S. S., Andrea J., Joshi S., Mantel N. Hepatocarcinogenicity of griseofulvin following parenteral administration to infant mice. Cancer Res. 1967 Oct;27(10):1900–1906. [PubMed] [Google Scholar]
  19. Epstein S. S., Arnold E., Andrea J., Bass W., Bishop Y. Detection of chemical mutagens by the dominant lethal assay in the mouse. Toxicol Appl Pharmacol. 1972 Oct;23(2):288–325. doi: 10.1016/0041-008x(72)90192-5. [DOI] [PubMed] [Google Scholar]
  20. Fawcett D. W., Anderson W. A., Phillips D. M. Morphogenetic factors influencing the shape of the sperm head. Dev Biol. 1971 Oct;26(2):220–251. doi: 10.1016/0012-1606(71)90124-2. [DOI] [PubMed] [Google Scholar]
  21. Ferreira N. R., Buoniconti A. The royal commission and London. Lancet. 1968 Dec 14;2(7581):1304–1304. doi: 10.1016/s0140-6736(68)91805-9. [DOI] [PubMed] [Google Scholar]
  22. Fritz H., Hess R. Prenatal development in the rat following administration of cyclamate, saccharin and sucrose. Experientia. 1968 Nov 15;24(11):1140–1141. doi: 10.1007/BF02147812. [DOI] [PubMed] [Google Scholar]
  23. Fritz H., Müller D., Hess R. Embryolethality in the mouse following treatment of males with cyclophosphamide at specific germ cell stages. Agents Actions. 1973 May;3(1):35–37. doi: 10.1007/BF02023849. [DOI] [PubMed] [Google Scholar]
  24. Gabridge M. G., Legator M. S. A host-mediated microbial assay for the detection of mutagenic compounds. Proc Soc Exp Biol Med. 1969 Mar;130(3):831–834. doi: 10.3181/00379727-130-33666. [DOI] [PubMed] [Google Scholar]
  25. Gaines T. B., Kimbrough R. D. The sterilizing, carcinogenic and teratogenic effects of metepa in rats. Bull World Health Organ. 1966;34(2):317–320. [PMC free article] [PubMed] [Google Scholar]
  26. Gaulier M., Roux C. Action tératogène du busulfan chez le rat. C R Seances Soc Biol Fil. 1970;164(10):1917–1919. [PubMed] [Google Scholar]
  27. Gebhart E., Schwanitz G., Hartwich G. Chromosomenaberrationen bei Busulfan-Behandlung. Dtsch Med Wochenschr. 1974 Jan 11;99(2):52–56. doi: 10.1055/s-0028-1107711. [DOI] [PubMed] [Google Scholar]
  28. Generoso W. M. Chemical induction of dominant lethals in female mice. Genetics. 1969 Feb;61(2):461–470. doi: 10.1093/genetics/61.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gilbert E. F., Pistey W. R. Effect on the offspring of repeated caffeine administration to pregnant rats. J Reprod Fertil. 1973 Sep;34(3):495–499. doi: 10.1530/jrf.0.0340495. [DOI] [PubMed] [Google Scholar]
  30. Gillett J. W., Harr J. R., Lindstrom F. T., Mount D. A., St Clair A. D., Weber L. J. Evaluation of human health hazards on use of dichlorvos (DDVP), especially in resin strips. Residue Rev. 1972;44:115–159. doi: 10.1007/978-1-4615-8491-9_6. [DOI] [PubMed] [Google Scholar]
  31. Hall R. W., Gomes W. R. Testosterone levels in the serum and testes of growing rats following prenatal exposure to busulphan. J Reprod Fertil. 1973 Oct;35(1):131–134. doi: 10.1530/jrf.0.0350131. [DOI] [PubMed] [Google Scholar]
  32. Hart M. M., Adamson R. H., Fabro S. Prematurity and intrauterine growth retardation induced by DDT in the rabbit. Arch Int Pharmacodyn Ther. 1971 Aug;192(2):286–290. [PubMed] [Google Scholar]
  33. Hemsworth B. N. Embryopathies in the rat due to alkane sulphonates. J Reprod Fertil. 1968 Nov;17(2):325–334. doi: 10.1530/jrf.0.0170325. [DOI] [PubMed] [Google Scholar]
  34. Ingalls T. H., Curley F. J., Zappasodi P. Colchicine-induced craniofacial defects in the mouse embryo. Arch Environ Health. 1968 Mar;16(3):326–332. doi: 10.1080/00039896.1968.10665067. [DOI] [PubMed] [Google Scholar]
  35. JACKSON D., ROBSON J. M. The effect of methyl cholanthrene on growth and pregnancy. Br J Exp Pathol. 1958 Apr;39(2):133–138. [PMC free article] [PubMed] [Google Scholar]
  36. Jagiello G. M. Meiosis and inhibition of ovulation in mouse eggs treated with actinomycin D. J Cell Biol. 1969 Aug;42(2):571–574. doi: 10.1083/jcb.42.2.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Johnson G. A., Jalal S. M. DDT-induced chromosomal damage in mice. J Hered. 1973 Jan-Feb;64(1):7–8. doi: 10.1093/oxfordjournals.jhered.a108344. [DOI] [PubMed] [Google Scholar]
  38. Joneja M. G., LeLiever W. C. In vivo effects of vinblastine and podophyllin on dividing cells of DBA mouse fetuses. Can J Genet Cytol. 1973 Sep;15(3):491–495. doi: 10.1139/g73-060. [DOI] [PubMed] [Google Scholar]
  39. Kimbrough R. D., Gaines T. B. Effect of organic phosphorus compounds and alkylating agents on the rat fetus. Arch Environ Health. 1968 Jun;16(6):805–808. doi: 10.1080/00039896.1968.10665156. [DOI] [PubMed] [Google Scholar]
  40. Klein M. F., Beall J. R. Griseofulvin: a teratogenic study. Science. 1972 Mar 31;175(4029):1483–1484. doi: 10.1126/science.175.4029.1483. [DOI] [PubMed] [Google Scholar]
  41. LYON M. F., PHILLIPS R. J., SEARLE A. G. A test for mutagenicity of caffeine in mice. Z Vererbungsl. 1962;93:7–13. doi: 10.1007/BF00897016. [DOI] [PubMed] [Google Scholar]
  42. Lavappa K. S., Yerganian G. Latent meiotic anomalies related to an ancestral exposure to a mutagenic agent. Science. 1971 Apr 9;172(3979):171–174. doi: 10.1126/science.172.3979.171. [DOI] [PubMed] [Google Scholar]
  43. Legator M. S., Palmer K. A., Adler I. D. A collaborative study of in vivo cytogenetic analysis. I. Interpretation of slide preparations. Toxicol Appl Pharmacol. 1973 Mar;24(3):337–350. doi: 10.1016/0041-008x(73)90040-9. [DOI] [PubMed] [Google Scholar]
  44. Leonard A., Linden G. Observation of dividing spermatocytes for chromosome aberrations induced in mouse spermatogonia by chemical mutagens. Mutat Res. 1972 Nov;16(3):297–300. doi: 10.1016/0027-5107(72)90160-1. [DOI] [PubMed] [Google Scholar]
  45. Leonard A., Linden G. Observations sur les propriétés mutagéniques des cyclamates chez les mammiféres. C R Seances Soc Biol Fil. 1972 Nov 9;166(2):468–470. [PubMed] [Google Scholar]
  46. Linnik A. B. Eksperimental'noe izuchenie vozmozhnoi roli grizeoful'vina v kantserogeneze. Vestn Dermatol Venerol. 1972 Feb;46(2):49–51. [PubMed] [Google Scholar]
  47. MACLEOD J., HOTCHKISS R. S., SITTERSON B. W. RECOVERY OF MALE FERTILITY AFTER STERILIZATION BY NUCLEAR RADIATION. JAMA. 1964 Feb 29;187:637–641. [PubMed] [Google Scholar]
  48. MOUTSCHEN J. Differential sensitivity of mouse spermatogenesis to alkylating agents. Genetics. 1961 Mar;46:291–299. doi: 10.1093/genetics/46.3.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Moutschen J. Mutagenesis with methyl methanesulfonate in mouse. Mutat Res. 1969 Nov-Dec;8(3):581–588. doi: 10.1016/0027-5107(69)90076-1. [DOI] [PubMed] [Google Scholar]
  50. Mulvihill J. J. Caffeine as teratogen and mutagen. Teratology. 1973 Aug;8(1):69–72. doi: 10.1002/tera.1420080109. [DOI] [PubMed] [Google Scholar]
  51. Napalkov N. P., Alexandrov V. A. On the effects of blastomogenic substances on the organism during embryogenesis. Z Krebsforsch. 1968;71(1):32–50. doi: 10.1007/BF00524500. [DOI] [PubMed] [Google Scholar]
  52. Nomura T. An analysis of the changing urethan response of the developing mouse embryo in relation to mortality, malformation, and neoplasm. Cancer Res. 1974 Sep;34(9):2217–2231. [PubMed] [Google Scholar]
  53. OAKBERG E. F., DIMINNO R. L. X-ray sensitivity of primary spermatocytes of the mouse.int. Int J Radiat Biol Relat Stud Phys Chem Med. 1960 Apr;2:196–209. doi: 10.1080/09553006014550211. [DOI] [PubMed] [Google Scholar]
  54. RIGDON R. H., NEAL J. EFFECTS OF FEEDING BENZO(A)PYRENE ON FERTILITY, EMBRYOS, AND YOUNG MICE. J Natl Cancer Inst. 1965 Feb;34:297–305. doi: 10.1093/jnci/34.2.297. [DOI] [PubMed] [Google Scholar]
  55. Rigdon R. H., Rennels E. G. Effect of feeding benzpyrene on reproduction in the rat. Experientia. 1964 Apr 15;20(4):224–226. doi: 10.1007/BF02135417. [DOI] [PubMed] [Google Scholar]
  56. Rossi A., Sebastio L., Ventruto V. Studio cromosomico in 14 soggetti psoriasici trattati con idrossiurea o azathioprine. Minerva Med. 1973 May 9;64(32):1728–1732. [PubMed] [Google Scholar]
  57. SAVKUR L. D., BATRA B. K., SRIDHARAN B. N., SANGHVI L. D. Effect of 20-methylcholanthrene on mouse embryos. III. Strain C3H(Jax)--by caesarean section. J Reprod Fertil. 1962 Jun;3:422–424. doi: 10.1530/jrf.0.0030422. [DOI] [PubMed] [Google Scholar]
  58. Schleiermacher E. Chromosome aberrations in mitoses and meioses in vivo. Arch Toxikol. 1971;28(2):105–114. doi: 10.1007/BF00332385. [DOI] [PubMed] [Google Scholar]
  59. Schmid E., Bauchinger M. Comparison of the chromosome damage induced by radiation and cytoxan therapy in lymphocytes of patients with gynaecological tumours. Mutat Res. 1973 Oct;21(5):271–274. [PubMed] [Google Scholar]
  60. Schröder J. H., Hug O. Dominante LetALMUTATIONEN IN DER Nachkommenschaft bestrahlter männlicher Mäuse. 1. Untersuchung der Dosiswirkungsbeziehung und des Unterschiedes zwischen Ganz- und Teilkörperbestrahlung bei meiotischen und postmeiotischen Keimzellenstadien. Mutat Res. 1971 Feb;11(2):215–245. [PubMed] [Google Scholar]
  61. Sharon E., Jones J., Diamond H., Kaplan D. Pregnancy and azathioprine in systemic lupus erythrmatosus. Am J Obstet Gynecol. 1974 Jan 1;118(1):25–28. doi: 10.1016/s0002-9378(16)33638-9. [DOI] [PubMed] [Google Scholar]
  62. Short R. D., Gibson J. E. Development of cyclophosphamide activation and its implications in perinatal toxicity to mice. Toxicol Appl Pharmacol. 1971 May;19(1):103–110. doi: 10.1016/0041-008x(71)90194-3. [DOI] [PubMed] [Google Scholar]
  63. Sinkus A. G., Orlova R. S. Izmeneniia khromosom v kul'ture limfotsitov bol'nykh, podvergavshikhsia lecheniiu mitomitsinom. Tsitologiia. 1970 Mar;12(3):352–356. [PubMed] [Google Scholar]
  64. Soukup S., Takacs E., Warkany J. Chromosome changes in embryos treated with various teratogens. J Embryol Exp Morphol. 1967 Oct;18(2):215–226. [PubMed] [Google Scholar]
  65. Southam C. M., Tanaka S., Arata T., Simkovic D., Miura M., Petropulos S. F. Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog Exp Tumor Res. 1969;11:194–212. doi: 10.1159/000391394. [DOI] [PubMed] [Google Scholar]
  66. Stoner G. D., Shimkin M. B., Kniazeff A. J., Weisburger J. H., Weisburger E. K., Gori G. B. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res. 1973 Dec;33(12):3069–3085. [PubMed] [Google Scholar]
  67. Swann P. F., Magee P. N. Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate. Biochem J. 1968 Nov;110(1):39–47. doi: 10.1042/bj1100039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. TUCHMANN-DUPLESSIS H., MERCIER-PAROT L. PRODUCTION DE MALFORMATIONS DES MEMBRES CHEZ LE LAPIN PAR ADMINISTRATION D'UN ANTIM'ETABOLITE: L'AZATHIOPRINE. C R Hebd Seances Acad Sci. 1964 Nov 16;259:3648–3651. [PubMed] [Google Scholar]
  69. Tanimura T. Effects of mitomycin C administered at various stages of pregnancy upon mouse fetuses. Okajimas Folia Anat Jpn. 1968 Apr;44(5):337–355. doi: 10.2535/ofaj1936.44.5_337. [DOI] [PubMed] [Google Scholar]
  70. Thorpe E., Wilson A. B., Dix K. M., Blair D. Teratological studies with dichlorvos vapour in rabbits and rats. Arch Toxikol. 1972;30(1):29–38. doi: 10.1007/BF00605271. [DOI] [PubMed] [Google Scholar]
  71. Vesselinovitch S. D., Mihailovich N., Pietra G. The prenatal exposure of mice to urethan and the consequent development of tumors in various tissues. Cancer Res. 1967 Dec;27(12):2333–2337. [PubMed] [Google Scholar]
  72. Voogd C. E., Jacobs J. J., van der Stel J. J. On the mutagenic action of dichlorvos. Mutat Res. 1972 Dec;16(4):413–416. doi: 10.1016/0027-5107(72)90210-2. [DOI] [PubMed] [Google Scholar]
  73. Walker S. E., Bole G. G., Jr Augmented incidence of neoplasia in NZB-NZW mice treated with long-term cyclophosphamide. J Lab Clin Med. 1973 Oct;82(4):619–633. [PubMed] [Google Scholar]
  74. Weinstein D., Mauer I., Solomon H. M. The effects of caffeine on chromosomes of human lymphocytes. In vivo and in vitro studies. Mutat Res. 1972 Dec;16(4):391–399. doi: 10.1016/0027-5107(72)90207-2. [DOI] [PubMed] [Google Scholar]
  75. Zuckerberg C., Solari A. J. Centriolar changes induced by vinblastine sulphate in the seminiferous epithelium of the mouse. Exp Cell Res. 1973 Feb;76(2):470–475. doi: 10.1016/0014-4827(73)90407-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES